Health Condition 1: K279- Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation
Conditions
Interventions
None listed
Sponsors
Dr Reddys Laboratories Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjects must voluntarily give consent in writing to participate in the study by signing the Informed Consent Form (ICF) 2. Subjects of either sex diagnosed with acid peptic disease aged >=18 years and 3. Subject who has been prescribed omeprazole therapy as routine clinical management as per Investigator discretion.
Exclusion criteria
Exclusion criteria: 1. Hyper-sensitivity to any Proton pump inhibitor including omeprazole in the past. 2. Participated in an investigational drug or investigational device study within 30 days prior to the start of the study 3. Prior treatment for acid peptic disease histamine-2 receptor antagonists or over the counter antacids during the week immediately before the study 4. Any medical condition according to investigator which may interfere with the treatment. Makes patient illegible for participation in study. 5. Planned surgical procedure during the duration of the study. 6. Women who are pregnant or breast-feeding and women who could become pregnant during the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate Patient Assessment of Gastrointestinal Disorder Symptom Severity Index (PAGI-SYM) at Day 14Timepoint: Baseline, Day 14 | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate Patient Assessment of Gastrointestinal Disorder Symptom Severity Index (PAGI-SYM) at Day 28Timepoint: Baseline, Day 28;To evaluate Patient overall treatment satisfaction on Day 28Timepoint: Day 28;To evaluate Patients overall treatment satisfaction on Day 14Timepoint: Day 14 | — |
Countries
India
Contacts
Public ContactSucheta Pandit
Dr. Reddys Laboratories
Outcome results
None listed